Cyclacel Pharmaceuticals ( CYCC) is a development-stage biopharmaceutical company dedicated to the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases. This stock is trading up 7.8% to $7 in recent trading. Today's Range: $6.41-$7.40 52-Week Range: $2.73-$7.93 Volume: 369,000 Three-Month Average Volume: 128,783 >>4 Stocks Showing Strength in a Weak Market From a technical perspective, CYCC is ripping higher here with above-average volume. This move is quickly pushing CYCC within range of triggering a major breakout trade. That trade will hit once CYCC manages to take out some near-term overhead resistance at $7.93 with high volume. Traders should now look for long-biased trades in CYCC as long as it's trending above today's low of $6.41, and then once it sustains a move or close above $7.93 with volume that hits near or above 128,783 shares. If that breakout triggers soon, then CYCC will set up to re-test or possibly take out its next major overhead resistance levels at $9 to $10. To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.